| __timestamp | ACADIA Pharmaceuticals Inc. | Vericel Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 17293000 |
| Thursday, January 1, 2015 | 76369000 | 26470000 |
| Friday, January 1, 2016 | 4406000 | 28307000 |
| Sunday, January 1, 2017 | 13060000 | 30354000 |
| Monday, January 1, 2018 | 18330000 | 32160000 |
| Tuesday, January 1, 2019 | 19598000 | 37571000 |
| Wednesday, January 1, 2020 | 20550000 | 39951000 |
| Friday, January 1, 2021 | 19141000 | 50159000 |
| Saturday, January 1, 2022 | 10166000 | 54577000 |
| Sunday, January 1, 2023 | 45731000 | 61940000 |
Unleashing the power of data
In the ever-evolving world of biotechnology, understanding financial health is crucial. This analysis delves into the cost of revenue trends for ACADIA Pharmaceuticals Inc. and Vericel Corporation from 2014 to 2023. Over this period, Vericel Corporation has shown a consistent upward trajectory, with its cost of revenue increasing by approximately 258%, peaking at $61.94 million in 2023. In contrast, ACADIA Pharmaceuticals Inc. experienced fluctuations, with a notable dip in 2016, but rebounded to a high of $45.73 million in 2023. This divergence highlights Vericel's steady growth and ACADIA's volatile yet resilient performance. Such insights are invaluable for investors and stakeholders aiming to navigate the complex biotech landscape. As these companies continue to innovate, monitoring their financial strategies will be key to understanding their market positions.
Comparing Cost of Revenue Efficiency: Johnson & Johnson vs Vericel Corporation
Cost Insights: Breaking Down Incyte Corporation and ACADIA Pharmaceuticals Inc.'s Expenses
Cost of Revenue Trends: Viatris Inc. vs Vericel Corporation
Bio-Techne Corporation vs Vericel Corporation: Efficiency in Cost of Revenue Explored
BioMarin Pharmaceutical Inc. vs ACADIA Pharmaceuticals Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Sarepta Therapeutics, Inc. and ACADIA Pharmaceuticals Inc.
Cost of Revenue Comparison: Halozyme Therapeutics, Inc. vs ACADIA Pharmaceuticals Inc.
Cost Insights: Breaking Down Bausch Health Companies Inc. and Vericel Corporation's Expenses
Comparing Cost of Revenue Efficiency: Vericel Corporation vs Wave Life Sciences Ltd.
Comparing Cost of Revenue Efficiency: Vericel Corporation vs Amphastar Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Vericel Corporation vs BioCryst Pharmaceuticals, Inc.